SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 NGS Genetic DNA Test
Comprehensive Genetic Testing for Epilepsy Disorders
The SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics. This specialized test focuses on identifying mutations in the SCN9A gene, which encodes the sodium channel protein type 9 subunit alpha. This protein plays a critical role in nerve cell communication and signal transmission throughout the nervous system. When mutations occur in this gene, they can disrupt normal sodium channel function, leading to abnormal electrical activity in the brain that manifests as epilepsy and seizure disorders.
What Does This Test Measure?
This advanced genetic test specifically targets and analyzes the SCN9A gene using Next-Generation Sequencing (NGS) technology to detect:
- Point mutations and single nucleotide variants in the SCN9A gene
- Small insertions and deletions affecting gene function
- Genetic variations associated with generalized epilepsy with febrile seizures plus type 7
- Inheritance patterns and familial risk factors
- Specific sodium channel abnormalities that contribute to seizure susceptibility
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Recurrent febrile seizures beyond typical childhood age (usually after age 6)
- Multiple seizure types including generalized tonic-clonic, absence, or myoclonic seizures
- Family history of epilepsy or seizure disorders
- Unexplained neurological symptoms with suspected genetic origin
- Children with developmental delays accompanied by seizure activity
- Patients with treatment-resistant epilepsy seeking genetic explanations
- Individuals planning family expansion with known epilepsy in family history
Clinical Benefits of Genetic Testing
Undergoing the SCN9A gene test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of epilepsy
- Personalized Treatment: Enables targeted medication selection based on genetic profile
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Prognostic Information: Helps predict disease course and potential complications
- Early Intervention: Facilitates timely management strategies for at-risk family members
- Reduced Diagnostic Uncertainty: Eliminates prolonged diagnostic odysseys
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists:
- Positive Result: Indicates the presence of a pathogenic mutation in the SCN9A gene associated with epilepsy. This confirms the genetic diagnosis and provides guidance for management.
- Negative Result: Suggests no detectable mutation in the SCN9A gene, though other genetic or non-genetic causes should still be considered.
- Variant of Uncertain Significance: Some genetic changes may have unknown clinical implications requiring further evaluation.
- Carrier Status: Identifies individuals who carry the mutation but may not show symptoms.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
| Specialty | Neurology and Genetics |
Pre-Test Preparation
Before undergoing testing, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session to discuss implications and expectations
- Development of detailed family pedigree chart
- Review of potential psychological and emotional impacts
- Discussion of insurance coverage and financial considerations
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurologists ensures consistent, high-quality care regardless of location.
Take Control of Your Neurological Health
Understanding the genetic basis of epilepsy can transform your approach to treatment and management. With our advanced SCN9A gene testing, you gain access to cutting-edge genetic insights that can guide your healthcare journey. Our team of specialists is committed to providing comprehensive support throughout the testing process and beyond.
Ready to take the next step in understanding your neurological health? Book your SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 NGS Genetic DNA Test today by calling our dedicated genetic counseling team at +1(267) 388-9828 or schedule your consultation through our online booking system.
